【調査レポート】世界の馬用医薬品&サプリメント市場2023年：企業・地域・種類・用途別分析

• 英文タイトル：Global Equine Drugs and Supplement Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の馬用医薬品&サプリメント市場2023年：企業・地域・種類・用途別分析 / Global Equine Drugs and Supplement Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC308GR11425資料のイメージです。

• レポートコード：MRC308GR11425
• 出版社/出版日：GlobalInfoResearch / 2023年8月
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（2-3営業日）
• 産業分類：医薬品＆ヘルスケア

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥772,560 (USD5,220)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

GlobalInfoResearchの最新の調査によると、世界の馬用医薬品&サプリメントの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の馬用医薬品&サプリメント市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 馬用医薬品&サプリメントの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため

馬用医薬品&サプリメント市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・サプリメント、医薬品

用途別セグメント
・ドラッグストア、動物病院、その他

主要な市場プレーヤー
・Bayer Animal Health、Boehringer Ingelheim、Elanco (Eli Lilly)、Merck Animal Health、Merial、Novartis Animal Health、Zoetis

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、馬用医薬品&サプリメント製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な馬用医薬品&サプリメントメーカーの企業概要、2019年～2022年までの馬用医薬品&サプリメントの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な馬用医薬品&サプリメントメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別馬用医薬品&サプリメントの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの馬用医薬品&サプリメントの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での馬用医薬品&サプリメント市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および馬用医薬品&サプリメントの産業チェーンを掲載しています。
・第14、15章では、馬用医薬品&サプリメントの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
– 馬用医薬品&サプリメントの概要
– 種類別分析（2018年vs2022年vs2029年）：サプリメント、医薬品
– 用途別分析（2018年vs2022年vs2029年）：ドラッグストア、動物病院、その他
– 世界の馬用医薬品&サプリメント市場規模・予測
– 世界の馬用医薬品&サプリメント生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Bayer Animal Health、Boehringer Ingelheim、Elanco (Eli Lilly)、Merck Animal Health、Merial、Novartis Animal Health、Zoetis
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：サプリメント、医薬品
・用途別分析2018年-2029年：ドラッグストア、動物病院、その他
・馬用医薬品&サプリメントの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・馬用医薬品&サプリメントのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・馬用医薬品&サプリメントのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・馬用医薬品&サプリメントの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・馬用医薬品&サプリメントの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Equine Drugs and Supplement
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Equine Drugs and Supplement Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Supplements
1.3.3 Pharmaceutical Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Equine Drugs and Supplement Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Drugstores
1.4.3 Veterinary Hospitals
1.4.4 Others
1.5 Global Equine Drugs and Supplement Market Size & Forecast
1.5.1 Global Equine Drugs and Supplement Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Equine Drugs and Supplement Sales Quantity (2018-2029)
1.5.3 Global Equine Drugs and Supplement Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer Animal Health
2.1.1 Bayer Animal Health Details
2.1.2 Bayer Animal Health Major Business
2.1.3 Bayer Animal Health Equine Drugs and Supplement Product and Services
2.1.4 Bayer Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Animal Health Recent Developments/Updates
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Equine Drugs and Supplement Product and Services
2.2.4 Boehringer Ingelheim Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments/Updates
2.3 Elanco (Eli Lilly)
2.3.1 Elanco (Eli Lilly) Details
2.3.2 Elanco (Eli Lilly) Major Business
2.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Product and Services
2.3.4 Elanco (Eli Lilly) Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Elanco (Eli Lilly) Recent Developments/Updates
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business
2.4.3 Merck Animal Health Equine Drugs and Supplement Product and Services
2.4.4 Merck Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Animal Health Recent Developments/Updates
2.5 Merial
2.5.1 Merial Details
2.5.2 Merial Major Business
2.5.3 Merial Equine Drugs and Supplement Product and Services
2.5.4 Merial Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merial Recent Developments/Updates
2.6 Novartis Animal Health
2.6.1 Novartis Animal Health Details
2.6.2 Novartis Animal Health Major Business
2.6.3 Novartis Animal Health Equine Drugs and Supplement Product and Services
2.6.4 Novartis Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Animal Health Recent Developments/Updates
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Equine Drugs and Supplement Product and Services
2.7.4 Zoetis Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Zoetis Recent Developments/Updates
3 Competitive Environment: Equine Drugs and Supplement by Manufacturer
3.1 Global Equine Drugs and Supplement Sales Quantity by Manufacturer (2018-2023)
3.2 Global Equine Drugs and Supplement Revenue by Manufacturer (2018-2023)
3.3 Global Equine Drugs and Supplement Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Equine Drugs and Supplement by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Equine Drugs and Supplement Manufacturer Market Share in 2022
3.4.2 Top 6 Equine Drugs and Supplement Manufacturer Market Share in 2022
3.5 Equine Drugs and Supplement Market: Overall Company Footprint Analysis
3.5.1 Equine Drugs and Supplement Market: Region Footprint
3.5.2 Equine Drugs and Supplement Market: Company Product Type Footprint
3.5.3 Equine Drugs and Supplement Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Equine Drugs and Supplement Market Size by Region
4.1.1 Global Equine Drugs and Supplement Sales Quantity by Region (2018-2029)
4.1.2 Global Equine Drugs and Supplement Consumption Value by Region (2018-2029)
4.1.3 Global Equine Drugs and Supplement Average Price by Region (2018-2029)
4.2 North America Equine Drugs and Supplement Consumption Value (2018-2029)
4.3 Europe Equine Drugs and Supplement Consumption Value (2018-2029)
4.4 Asia-Pacific Equine Drugs and Supplement Consumption Value (2018-2029)
4.5 South America Equine Drugs and Supplement Consumption Value (2018-2029)
4.6 Middle East and Africa Equine Drugs and Supplement Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
5.2 Global Equine Drugs and Supplement Consumption Value by Type (2018-2029)
5.3 Global Equine Drugs and Supplement Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
6.2 Global Equine Drugs and Supplement Consumption Value by Application (2018-2029)
6.3 Global Equine Drugs and Supplement Average Price by Application (2018-2029)
7 North America
7.1 North America Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
7.2 North America Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
7.3 North America Equine Drugs and Supplement Market Size by Country
7.3.1 North America Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
7.3.2 North America Equine Drugs and Supplement Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
8.2 Europe Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
8.3 Europe Equine Drugs and Supplement Market Size by Country
8.3.1 Europe Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
8.3.2 Europe Equine Drugs and Supplement Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Equine Drugs and Supplement Market Size by Region
9.3.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
10.2 South America Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
10.3 South America Equine Drugs and Supplement Market Size by Country
10.3.1 South America Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
10.3.2 South America Equine Drugs and Supplement Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Equine Drugs and Supplement Market Size by Country
11.3.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Equine Drugs and Supplement Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Equine Drugs and Supplement Market Drivers
12.2 Equine Drugs and Supplement Market Restraints
12.3 Equine Drugs and Supplement Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Equine Drugs and Supplement and Key Manufacturers
13.2 Manufacturing Costs Percentage of Equine Drugs and Supplement
13.3 Equine Drugs and Supplement Production Process
13.4 Equine Drugs and Supplement Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Equine Drugs and Supplement Typical Distributors
14.3 Equine Drugs and Supplement Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Equine Drugs and Supplement Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Equine Drugs and Supplement Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Animal Health Major Business
Table 5. Bayer Animal Health Equine Drugs and Supplement Product and Services
Table 6. Bayer Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Animal Health Recent Developments/Updates
Table 8. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer Ingelheim Major Business
Table 10. Boehringer Ingelheim Equine Drugs and Supplement Product and Services
Table 11. Boehringer Ingelheim Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer Ingelheim Recent Developments/Updates
Table 13. Elanco (Eli Lilly) Basic Information, Manufacturing Base and Competitors
Table 14. Elanco (Eli Lilly) Major Business
Table 15. Elanco (Eli Lilly) Equine Drugs and Supplement Product and Services
Table 16. Elanco (Eli Lilly) Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Elanco (Eli Lilly) Recent Developments/Updates
Table 18. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 19. Merck Animal Health Major Business
Table 20. Merck Animal Health Equine Drugs and Supplement Product and Services
Table 21. Merck Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Animal Health Recent Developments/Updates
Table 23. Merial Basic Information, Manufacturing Base and Competitors
Table 24. Merial Major Business
Table 25. Merial Equine Drugs and Supplement Product and Services
Table 26. Merial Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Merial Recent Developments/Updates
Table 28. Novartis Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Animal Health Major Business
Table 30. Novartis Animal Health Equine Drugs and Supplement Product and Services
Table 31. Novartis Animal Health Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Animal Health Recent Developments/Updates
Table 33. Zoetis Basic Information, Manufacturing Base and Competitors
Table 34. Zoetis Major Business
Table 35. Zoetis Equine Drugs and Supplement Product and Services
Table 36. Zoetis Equine Drugs and Supplement Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Zoetis Recent Developments/Updates
Table 38. Global Equine Drugs and Supplement Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Equine Drugs and Supplement Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Equine Drugs and Supplement Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Equine Drugs and Supplement, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Equine Drugs and Supplement Production Site of Key Manufacturer
Table 43. Equine Drugs and Supplement Market: Company Product Type Footprint
Table 44. Equine Drugs and Supplement Market: Company Product Application Footprint
Table 45. Equine Drugs and Supplement New Market Entrants and Barriers to Market Entry
Table 46. Equine Drugs and Supplement Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Equine Drugs and Supplement Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Equine Drugs and Supplement Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Equine Drugs and Supplement Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Equine Drugs and Supplement Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Equine Drugs and Supplement Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Equine Drugs and Supplement Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Equine Drugs and Supplement Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Equine Drugs and Supplement Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Equine Drugs and Supplement Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Equine Drugs and Supplement Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Equine Drugs and Supplement Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Equine Drugs and Supplement Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Equine Drugs and Supplement Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Equine Drugs and Supplement Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Equine Drugs and Supplement Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Equine Drugs and Supplement Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Equine Drugs and Supplement Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Equine Drugs and Supplement Raw Material
Table 106. Key Manufacturers of Equine Drugs and Supplement Raw Materials
Table 107. Equine Drugs and Supplement Typical Distributors
Table 108. Equine Drugs and Supplement Typical Customers
List of Figures
Figure 1. Equine Drugs and Supplement Picture
Figure 2. Global Equine Drugs and Supplement Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Equine Drugs and Supplement Consumption Value Market Share by Type in 2022
Figure 4. Supplements Examples
Figure 5. Pharmaceutical Drugs Examples
Figure 6. Global Equine Drugs and Supplement Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Equine Drugs and Supplement Consumption Value Market Share by Application in 2022
Figure 8. Drugstores Examples
Figure 9. Veterinary Hospitals Examples
Figure 10. Others Examples
Figure 11. Global Equine Drugs and Supplement Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Equine Drugs and Supplement Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Equine Drugs and Supplement Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Equine Drugs and Supplement Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Equine Drugs and Supplement Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Equine Drugs and Supplement Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Equine Drugs and Supplement by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Equine Drugs and Supplement Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Equine Drugs and Supplement Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Equine Drugs and Supplement Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Equine Drugs and Supplement Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Equine Drugs and Supplement Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Equine Drugs and Supplement Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Equine Drugs and Supplement Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 53. China Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Equine Drugs and Supplement Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Equine Drugs and Supplement Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Equine Drugs and Supplement Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Equine Drugs and Supplement Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Equine Drugs and Supplement Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Equine Drugs and Supplement Market Drivers
Figure 74. Equine Drugs and Supplement Market Restraints
Figure 75. Equine Drugs and Supplement Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Equine Drugs and Supplement in 2022
Figure 78. Manufacturing Process Analysis of Equine Drugs and Supplement
Figure 79. Equine Drugs and Supplement Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source

以下、関連資料のご紹介

世界の馬用医薬品・サプリメント市場予測 2023年-2029年

Global Equine Drugs and Supplement Market Growth 2023-2029
MRC2311L7094 2023年10月 92Pages
LPインフォメーションの最新刊調査レポート「世界の馬用医薬品・サプリメント市場」は、過去の販売実績から2022年の世界の馬用医薬品・サプリメントの総販売量を検討し、2023年から2029年の予測される馬用医薬品・サプリメントの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地...

世界の産後健康補助食品市場2023年：企業・地域・種類・用途別分析

Global Postnatal Health Supplement Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z7978 2023年9月 100Pages
GlobalInfoResearchの最新の調査によると、世界の産後健康補助食品の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。

世界のスクワレンサプリメント市場2023年：企業・地域・種類・用途別分析

Global Squalene Supplement Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z8063 2023年9月 104Pages
GlobalInfoResearchの最新の調査によると、世界のスクワレンサプリメントの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。<...

馬獣医治療の世界市場見通し2023年-2029年

Equine Veterinary Therapeutics Market, Global Outlook and Forecast 2023-2029
MRC2312MG11870 2023年12月 61Pages
当調査レポートは次の情報を含め、世界の馬獣医治療市場規模と予測を収録しています。・世界の馬獣医治療市場：売上、2018年-2023年、2024年-2029年
・世界の馬獣医治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のサプリメント用消化ジアミンオキシダーゼ酵素市場2023年：企業・地域・種類・用途別分析

Global Digestive Diamine Oxidase Enzyme for Supplement Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
MRC309Z7835 2023年9月 104Pages
GlobalInfoResearchの最新の調査によると、世界のサプリメント用消化ジアミンオキシダーゼ酵素の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規...